Johnson & Johnson
About
Aging Population Stocks
Johnson & Johnson's pharmaceutical and medical device portfolios are well-positioned to benefit from aging populations driving increased demand for oncology, immunology, and surgical treatments.
Blue Chip Stocks
Johnson & Johnson is a quintessential blue chip stock with over 130 years of operating history, a AAA credit rating held by very few corporations, and a diversified healthcare business that provides stability through virtually any economic cycle.
Dividend Aristocrat Stocks
Johnson & Johnson is a healthcare giant with over 60 consecutive years of dividend increases, anchored by leading pharmaceutical and medical device franchises across global markets.
Dividend Stocks
Johnson & Johnson is a Dividend King with over 60 consecutive years of annual dividend increases, backed by the stable and recession-resistant cash flows of its pharmaceutical and medical device businesses. Its long track record of reliable dividend growth makes it a premier dividend stock for investors seeking dependable healthcare-sector income.
Key Financials JNJ
Data updated Feb 15 · Source: Twelve Data
